Table 1

Clinicopathological features of patients with LELC of the parotid gland described in the Western literature
Author Sex Age Treatment Clinical outcome EBER Other data
Ferlito A, 1977 [30] F 36 SP At the last follow-up, no signs of relapse n.a. Cervical lymph node metastasis
Ferlito A, 1977 [30] F 55 SP At the last follow-up, no signs of relapse n.a. n.a.
Ferlito A, 1977 [30] F 32 RP At the last follow-up, no signs of relapse n.a. n.a.
Kott ET, 1984 [31] M 51 RT At 11-year follow-up, no signs of relapse n.a. Cervical lymph node metastasis
Kott ET, 1984 [31] F 42 SP + RT At 12-month follow-up, no signs of relapse n.a. n.a.
Kountakis Se,1995 [1] F 68 SP + RT At 24-month follow-up, no signs of relapse negative Metastasis to intraparotid lymph node
Kountakis Se, 1995 [1] F 57 RP + RT At 24-month follow-up, no signs of relapse negative Lymph node metastasis
Kotsianti A, 1996 [32] M 64 SP At the last follow-up, no signs of relapse positive Regional lymph node metastasis
Squillaci S, 2000 [27] F 45 SP + RT At 15-month follow-up, no signs of relapse positive n.a.
Wu DL, 2001 [26] F 54 RP + RT At 24-month follow-up, no signs of relapse positive n.a.
Squillaci S, 2002 [4] F 72 SP + RT At 36-month follow-up, no signs of relapse positive Periparotid lymph node metastasis
Bialas M, 2002 [28] F 74 RT n.a. positive n.a.
Ayache S, 2004 [25] M 47 RP + RT At 7-month follow-up, no signs of relapse negative Neural metastasis
Manganaris A, 2007 [29] F 67 SP + RT At 12-month follow-up, no signs of relapse n.a. n.a.

RP radical parotidectomy, SP superficial parotidectomy, RT radiotherapy, n.a. not available.

Ambrosio et al.

Ambrosio et al. Diagnostic Pathology 2013 8:115   doi:10.1186/1746-1596-8-115

Open Data